NAVROGEN
Navrogen Inc. is a biopharmaceutical company focused on the targeted treatment of cancer. Navrogen is currently working on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells which inhibit the cancer-fighting humoral immune system.
NAVROGEN
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2017-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.navrogen.com
Total Employee:
1+
Status:
Active
Contact:
(610) 660-1931
Total Funding:
6.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin ReCAPTCHA Yoast SEO Premium Yoast Plugins Contact Form 7
Similar Organizations
Regenica Biosciences
Regenica is a clinical stage biopharmaceutical company engaged in the development of treatments for serious unmet medical needs.
Rancho BioSciences
Rancho BioSciences is a pharmaceutical company providing knowledge management and genetic variant annotation.
ReAlta Life Sciences
ReAlta is a clinical-stage biotech company dedicated to harnessing the power of the immune system to address life threatening rare diseases.
Reveal Pharmaceuticals
Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.
Nomi Biotech Corporation
Nomi Biotech is a dynamic Polish - Japanese biotech company focused on a development of science based nutraceuticals.
NMB Therapeutics
NMB Therapeutics is a pharmaceutical company that develops products to provide efficient drug delivery.
QurCan Therapeutics Inc.
QurCan Therapeutics (formerly known as Nanology Labs) is a biotech company developing next-generation nanoparticles for gene/chemotherapy.
Vivtex
Vivtex is a pre-clinical drug development company that focuses on therapies for GI-related diseases using oral oligonucleotide therapeutics.
VastCon
VastCon Inc. is a biotech company developing early screening and diagnostics for cancer.
MYND Life Sciences
MYND Life Sciences is a life sciences company focused on novel psychedelic drug development and pharmaceuticals.
Mucpharm
Mucpharm is a clinical-stage biopharma company focused on the treatment of mucin-containing and secreting cancers.
MicroQuin
MicroQuin is a pre-clinical biotechnology company with first-in-class, lead compounds that use two technologies to kill breast cancers
Myome
Myome helps identify genes that cause disease and act based on leading science.
Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases
Lymphact
Lymphact is a biopharmaceutical start-up focused on developing innovative personalized medical treatments.
LONGFU
LONGFU is a pharmaceutical company that provides drug research and development services.
Arbor Pharmaceuticals
Arbor Pharmaceuticals is a specialty pharmaceutical company developing late-stage therapeutic products for common pediatric conditions.
Allonnia
Allonnia is an environmental biotechnology company focused on metals and mining, plastics and PFAS, plus other emerging contaminants.
Atropos Therapeutics
Atropos Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer.
Anji Pharmaceuticals
Anji Pharmaceuticals is focused on tackling high-value targets validated by human genetics.
Advenchen Laboratories
Advenchen is a pharmaceutical company focusing on pharmaceutical research and development of small molecule cancer drug discovery programs.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
AptaTargets
AptaTargets is a biopharmaceutical company focused in developing therapeutic
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Emalex Biosciences, Inc.
Emalex Biosciences is a biopharmaceutical company dedicated to the development of new and novel treatments.
BioNovion
BioNovion is a biopharmaceutical company specialized in immune oncology antibody discovery.
BioRem.mx
BioRemis a proudly Mexican company specialized in the bioremediation industry.
TechAccel
TechAccel is a technology and venture development company focused on the advancement of science in agriculture and animal health.
TauC3 Biologics Limited
biopharmaceutical company focused on the development of innovative immunotherapies for the treatment of tauopathies.
Theriana Pharmaceuticals
Theriana Pharmaceuticals, Inc. manufactures pharmaceuticals
Tactogen
Tactogen is a biopharma startup that develops empathogen medicines.
URL Pharma, Inc.
URL Pharma is a pharmaceuticals company specializing in drug research and development services.
Karus Therapeutics
Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.
WEP Clinical
WEP Clinical is a specialist pharma services company that works with drug developers.
WeHand
WeHand is a biopharmaceutical company focusing on the development of hypoglycemic drugs.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Semnur Pharmaceuticals
Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Sisu Pharma
Sisu Pharma is developing drugs against a new target to treat prostate cancer.
Seneca Therapeutics
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Double Bond Pharmaceutical
Double Bond Pharmaceutical company which develops and commercialises innovative first-in-class approaches for treatment of cancers.
HiProMine
Supplier of insects origin protein feed. Target markets: petfood, fish breeding/aquaculture, animal breeding, agricultural fertilizers.
HepatoChem
HepatoChem is a service company that provides pharmaceutical and biotech companies with access to small molecule metabolites.
Igenica
Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.
Grow Group
Grow is a biopharmaceutical company focused solely on cannabis based medicines and improving global access to those medicines.
P&PMed
P&PMed is the first biomedical company to focus on the research and application of personalized cancer vaccines.
Glionova
Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer.
GEEN Biotechnology
GEEN Biotechnology is a synthetic biology company developing master cells & genetic technologies for industrial production of biomolecules.
Catena Biosciences
Biotech company focused on protein conjugation.
Ciclofilin Pharmaceuticals
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors.
Cortene
Cortene is a clinical-stage biopharmaceutical company focused on developing treatments for chronic fatigue syndrome and other diseases.
Cultiply
Cultiply is a biotechnology company focused on the innovation and optimization of industrial fermentation processes.
Crestovo
Crestovo is a clinical-stage biopharmaceutical company developing Full-Spectrum Microbiota that harnesses the human gut microbiome.
Prokaryotics
Prokaryotics is a biopharmaceutical company focused on the discovery and development of novel antibiotic classes.
Polaris Genomics
Harnessing genomics, we make invisible wounds like PTSD visible.
PetDx
PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.
Perception Neuroscience
Perception Neuroscience is a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry.
Panag Pharma
Panag Pharma is a bio-tech company focused on the development of novel cannabinoid.
Pyrefin
Pyrefin is a development-stage pharmaceutical company focused on producing EP2 receptor antagonists.
Yael Capital Management Limited
Yael Capital focuses on private equity investment and fund management.
Ymmuno Biotech
Using IgY as an oral immunotherapy for infectious disease, focused in research and development to reduce antibiotics resistance
Current Employees Featured
Founder
Investors List
Tellus BioVentures
Tellus BioVentures investment in Seed Round - Navrogen
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Convertible Note - Navrogen
Official Site Inspections
http://www.navrogen.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: 104.21.70.11
- IP address: 104.21.70.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Navrogen"
Navrogen - Leading the Way in Humoral Immuno-Oncology
Our mission is to develop therapeutic agents that can overcome the immunosuppressive effects of factors that suppress humoral immune responses produced by tumors as well as develop …See details»
About Navrogen
Drs. Nicolaides and Grasso co-founded Navrogen in 2018 to pioneer the development of first-in-class agents that can overcome the immunosuppressive effects of HIO factors by employing …See details»
Pipeline - Navrogen
NAV-006 is being developed for treating HIO-1-positive Non-Hodgkin’s Lymphoma. is a small-molecule compound that binds to CD16/Fc Receptor and activates NK cells, which go on to kill tumor cells (figure). NAV-201 can …See details»
Navrogen - Crunchbase Company Profile & Funding
Navrogen Inc. is a biopharmaceutical company that focuses on the targeted treatment of cancer. The company works on enhancing the immune system to fight cancer by removing the effect …See details»
Navrogen - LinkedIn
Finding cures with you in mind | Navrogen Inc. is a biopharmaceutical company focused on the targeted treatment of cancer. Navrogen is currently working on enhancing the immune system …See details»
Navrogen - Ben Franklin Technology Partners
Biotech focused on enhancing the immune system to fight cancer by removing the effect of factors produced or induced by tumor cells which inhibit the cancer-fighting humoral immune system.See details»
Navrogen Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Navrogen. Use the PitchBook Platform to explore the full profile.See details»
Navrogen Announces Publication of NAV-001 Antibody-Drug …
CHEYNEY, Pa., May 18, 2023 /PRNewswire/ -- Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, announces …See details»
Navrogen - Products, Competitors, Financials, Employees, …
Navrogen provides biopharmaceutical solutions focusing on developing therapeutic agents and diagnostic tools in the Humoral Immuno-Oncology domain. Use the CB Insights Platform to …See details»
Navrogen Closes $3.0M Seed Financing To Advance Its Preclinical ...
CHEYNEY, Pa., Aug. 9, 2021 /PRNewswire/ -- Navrogen, Inc., a privately held preclinical biotechnology company, announced today that it has raised $3.0M from an equity financing to …See details»
Technology - Navrogen
Our proprietary Block-Removed Immunoglobulin Technology (BRITE) and screening platforms enable us to engineer antibodies to be refractory or antagonist to the immunosuppression mediated by the HIO factors. Visit our …See details»
Navrogen Inc. and Tavotek Biotherapeutics Announce Strategic ...
Aug 17, 2021 · Under the agreement, Navrogen and Tavotek will collaborate on the development of future Tavotek oncology assets while utilizing Navrogen's proprietary screening technology …See details»
Navrogen - Contacts, Employees, Board Members, Advisors
Navrogen has 2 current employee profiles, including President, Chief Executive Officer and Co-Founder Nicholas Nicolaides. Navrogen is a biopharmaceutical company that focuses on the …See details»
News Archive - Navrogen
Nov 7, 2022 · Cheyney, PA, April 4, 2024 — Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, will present …See details»
Navrogen - Funding, Financials, Valuation & Investors - Crunchbase
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.See details»
Navrogen and Levena Announce Collaboration to Develop …
Feb 4, 2020 · ADCs developed under this collaboration combine Levena's linker and cytotoxic payload chemistry expertise along with Navrogen's cancer-targeting antibodies discovered …See details»
Navrogen Announces Publication of NAV-001 Antibody-Drug …
May 18, 2023 · NAV-001 ADC targets the cell surface mesothelin protein that is over-expressed by a number of cancers including triple negative breast, metastatic colorectal, non-small cell …See details»
Navrogen Announces Publication of NAV-001 Antibody-Drug …
May 18, 2023 · NAV-001 ADC targets the cell surface mesothelin protein that is over-expressed by a number of cancers including triple negative breast, metastatic colorectal, non-small cell …See details»
Navrogen Company Profile - Office Locations, Competitors ... - Craft
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer. It works on enhancing the immune system to fight cancer by removing the effect of factors produced or …See details»
Publications Archive - Navrogen
Poster Presentation. CA125 immunosuppresses CD19/CD20 antibodies and bispecifics, while NAV-006 escapes this mechanismSee details»